A Post-Marketing Safety Study to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy in an Integrated Healthcare System in the United States (C3671042)

19/08/2026
19/08/2026
EU PAS number:
EUPAS1000001074
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C3671042_RSV VACCINE PROTOCOL AMENDMENT 3 VERSION 3.1_03FEB2026.pdf

English (1.82 MB - PDF) View document
Study results
Study report
Other information